Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-14

FDA Approved: TRANEXAMIC ACID — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for tranexamic acid from Mylan Institutional LLC, granting approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

SUPPL AP for TRANEXAMIC ACID (TRANEXAMIC ACID)